BIO-RAD LABORATORIES, INC. Quarterly Amortization of Intangible Assets in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2011 to Q3 2024.
  • Bio Rad Laboratories, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $5.3M, a 14.5% decline year-over-year.
  • Bio Rad Laboratories, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $21.8M, a 9.92% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Amortization of Intangible Assets for 2023 was $23.8M, a 4.42% decline from 2022.
  • Bio Rad Laboratories, Inc. annual Amortization of Intangible Assets for 2022 was $24.9M, a 12.3% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Amortization of Intangible Assets for 2021 was $28.4M, a 3.27% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $21.8M $5.3M -$900K -14.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $22.7M $5.3M -$600K -10.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $23.3M $5.5M -$500K -8.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $23.8M $5.7M -$400K -6.56% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $24.2M $6.2M $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $24.2M $5.9M -$400K -6.35% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $24.6M $6M -$300K -4.76% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $24.9M $6.1M -$600K -8.96% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $25.5M $6.2M -$1.1M -15.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $26.6M $6.3M -$900K -12.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $27.5M $6.3M -$900K -12.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $28.4M $6.7M -$500K -6.94% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $28.9M $7.3M +$100K +1.39% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $28.8M $7.2M $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $28.8M $7.2M +$1.3M +22% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $27.5M $7.2M +$800K +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $26.7M $7.2M +$1.2M +20% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $25.5M $7.2M +$1.6M +28.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $23.9M $5.9M +$400K +7.27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $23.5M $6.4M -$100K -1.54% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $23.6M $6M -$1M -14.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $24.6M $5.6M -$1.8M -24.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $26.4M $5.5M -$1.9M -25.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $28.3M $6.5M -$900K -12.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $29.2M $7M -$800K -10.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $30M $7.4M -$1.3M -14.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $31.3M $7.4M +$500K +7.25% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $30.8M $7.4M +$700K +10.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $30.1M $7.8M -$1.7M -17.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $31.8M $8.7M -$900K -9.38% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $32.7M $6.9M -$2.5M -26.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $35.2M $6.7M -$2.1M -23.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-04-01
Q3 2016 $37.3M $9.5M +$300K +3.26% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $37M $9.6M +$300K +3.23% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $36.7M $9.4M +$200K +2.17% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $36.5M $8.8M -$6.2M -41.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-16
Q3 2015 $42.7M $9.2M -$1.7M -15.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $44.4M $9.3M -$1.7M -15.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $46.1M $9.2M -$1.7M -15.6% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $47.8M $15M +$3.3M +28.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $44.5M $10.9M -$200K -1.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $44.7M $11M -$100K -0.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $44.8M $10.9M -$200K -1.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $45M $11.7M +$1.1M +10.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $43.9M $11.1M +$400K +3.74% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $43.5M $11.1M +$400K +3.74% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $43.1M $11.1M +$300K +2.78% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $42.8M $10.6M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $10.7M +$1.1M +11.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $10.7M +$1.4M +15.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $10.8M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $9.6M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $9.3M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.